Literature DB >> 26776938

US family physicians' intrauterine and implantable contraception provision: results from a national survey.

Mollie B Nisen1, Lars E Peterson2, Anneli Cochrane3, Susan E Rubin4.   

Abstract

OBJECTIVE: Establish a current cross-sectional national picture of intrauterine device (IUD) and implant provision by US family physicians and ascertain individual, clinical site and scope of practice level associations with provision. STUDY
DESIGN: Secondary analysis of data from 2329 family physicians recertifying with the American Board of Family Medicine in 2014.
RESULTS: Overall, 19.7% of respondents regularly inserted IUDs, and 11.3% regularly inserted and/or removed implants. Family physicians provided these services in a wide range of clinical settings. In bivariate analysis, almost all of the individual, clinical site and scope of practice characteristics we examined were associated with provision of both methods. In multivariate analysis, the scope of practice characteristics showed the strongest association with both IUD and implant provision. For IUDs, this included providing prenatal care with [adjusted odds ratio (aOR) 3.26, 95% confidence interval (95% CI)=1.93-5.49] or without (aOR=3.38, 95% CI=1.88-6.06) delivery, performance of endometrial biopsies (aOR=16.51, 95% CI=11.97-22.79) and implant insertion and removal (aOR=8.78, 95% CI=5.79-13.33). For implants, it was providing prenatal care and delivery (aOR=1.77, 95% CI=1.15-2.74), office skin procedures (aOR=3.07, 95% CI=1.47-6.42), endometrial biopsies (aOR=3.67, 95% CI=2.41-5.59) and IUD insertion (aOR=8.58, 95% CI=5.70-12.91).
CONCLUSIONS: While a minority of family physicians regularly provided IUDs and/or implants, those who provided did so in a broad range of outpatient settings. Individual and clinical site characteristics were not largely predictive of provision. This connotes potential for family physicians to increase IUD and implant access in a variety of settings. Provision of both methods was strongly associated with scope of practice variables including performance of certain office procedures as well as prenatal and/or obstetrical care. IMPLICATIONS: These data provide a baseline from which to analyze change in IUD and implant provision in family medicine, identify gaps in care and ascertain potential leverage points for interventions to increase long-acting reversible contraceptive provision by family physicians. Interventions may be more successful if they first focus on sites and/or family physicians who already provide prenatal care, obstetrical care, skin procedures and/or endometrial biopsies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contraceptive implants; Family physicians; IUD; Intrauterine contraceptive device; LARC; Long-acting reversible contraception; Primary care

Mesh:

Substances:

Year:  2016        PMID: 26776938      PMCID: PMC4842114          DOI: 10.1016/j.contraception.2016.01.004

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  16 in total

1.  Reducing unintended pregnancy in the United States.

Authors:  James Trussell; L L Wynn
Journal:  Contraception       Date:  2007-12-03       Impact factor: 3.375

2.  IUD knowledge and experience among family medicine residents.

Authors:  Finn D Schubert; Cara Herbitter; Jason Fletcher; Marji Gold
Journal:  Fam Med       Date:  2015-06       Impact factor: 1.756

3.  Association of reproductive health training on intention to provide services after residency: the family physician resident survey.

Authors:  Diana Romero; Lisa Maldonado; Liza Fuentes; Linda Prine
Journal:  Fam Med       Date:  2015-01       Impact factor: 1.756

4.  Trends in long-acting reversible contraception use among U.S. women aged 15-44.

Authors:  Amy M Branum; Jo Jones
Journal:  NCHS Data Brief       Date:  2015-02

5.  Women or LARC first? Reproductive autonomy and the promotion of long-acting reversible contraceptive methods.

Authors:  Anu Manchikanti Gomez; Liza Fuentes; Amy Allina
Journal:  Perspect Sex Reprod Health       Date:  2014-05-23

Review 6.  Disparities in family planning.

Authors:  Christine Dehlendorf; Maria Isabel Rodriguez; Kira Levy; Sonya Borrero; Jody Steinauer
Journal:  Am J Obstet Gynecol       Date:  2010-03       Impact factor: 8.661

7.  Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial.

Authors:  Cynthia C Harper; Corinne H Rocca; Kirsten M Thompson; Johanna Morfesis; Suzan Goodman; Philip D Darney; Carolyn L Westhoff; J Joseph Speidel
Journal:  Lancet       Date:  2015-06-16       Impact factor: 79.321

8.  Determinants of intrauterine contraception provision among US family physicians: a national survey of knowledge, attitudes and practice.

Authors:  Susan E Rubin; Jason Fletcher; Tara Stein; Penina Segall-Gutierrez; Marji Gold
Journal:  Contraception       Date:  2010-12-03       Impact factor: 3.375

Review 9.  Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception.

Authors:  P D Blumenthal; A Voedisch; K Gemzell-Danielsson
Journal:  Hum Reprod Update       Date:  2010-07-15       Impact factor: 15.610

10.  Unmet demand for highly effective postpartum contraception in Texas.

Authors:  Joseph E Potter; Kristine Hopkins; Abigail R A Aiken; Celia Hubert; Amanda J Stevenson; Kari White; Daniel Grossman
Journal:  Contraception       Date:  2014-07-03       Impact factor: 3.051

View more
  2 in total

1.  Effects of the scope of practice on family physicians: a systematic review.

Authors:  Hervé Tchala Vignon Zomahoun; Isabelle Samson; Jasmine Sawadogo; José Massougbodji; Amédé Gogovor; Ella Diendéré; Frédéric Turgeon; France Légaré
Journal:  BMC Fam Pract       Date:  2021-01-08       Impact factor: 2.497

2.  Implementation science: Scaling a training intervention to include IUDs and implants in contraceptive services in primary care.

Authors:  Cynthia C Harper; Alison B Comfort; Maya Blum; Corinne H Rocca; Charles E McCulloch; Lavanya Rao; Nishant Shah; Helen Oquendo Del Toro; Suzan Goodman
Journal:  Prev Med       Date:  2020-10-21       Impact factor: 4.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.